These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Scale-up of antiretroviral treatment in sub-Saharan Africa is accompanied by increasing HIV-1 drug resistance mutations in drug-naive patients. Aghokeng AF; Kouanfack C; Laurent C; Ebong E; Atem-Tambe A; Butel C; Montavon C; Mpoudi-Ngole E; Delaporte E; Peeters M AIDS; 2011 Nov; 25(17):2183-8. PubMed ID: 21860346 [TBL] [Abstract][Full Text] [Related]
12. Surveillance of antiretroviral drug resistance mutations in untreated young children living in the Central African Republic. Charpentier C; Gody JC; Tisserand P; Matta M; Péré H; Fournier J; Mbitikon O; Bélec L Antivir Ther; 2011; 16(8):1347-50. PubMed ID: 22155917 [TBL] [Abstract][Full Text] [Related]
13. Prevalence of antiretroviral drug resistance mutations and HIV-1 non-B subtypes in newly diagnosed drug-naïve patients in Slovenia, 2000-2004. Babic DZ; Zelnikar M; Seme K; Vandamme AM; Snoeck J; Tomazic J; Vidmar L; Karner P; Poljak M Virus Res; 2006 Jun; 118(1-2):156-63. PubMed ID: 16417938 [TBL] [Abstract][Full Text] [Related]
14. High concordance between HIV-1 drug resistance genotypes generated from plasma and dried blood spots in antiretroviral-experienced patients. Masciotra S; Garrido C; Youngpairoj AS; McNulty A; Zahonero N; Corral A; Heneine W; de Mendoza C; García-Lerma JG AIDS; 2007 Nov; 21(18):2503-11. PubMed ID: 18025887 [TBL] [Abstract][Full Text] [Related]
15. Comparison of an Tzou PL; Ariyaratne P; Varghese V; Lee C; Rakhmanaliev E; Villy C; Yee M; Tan K; Michel G; Pinsky BA; Shafer RW J Clin Microbiol; 2018 Jun; 56(6):. PubMed ID: 29618499 [TBL] [Abstract][Full Text] [Related]
16. Short Communication: Population-Based Surveillance of HIV-1 Drug Resistance in Cameroonian Adults Initiating Antiretroviral Therapy According to the World Health Organization Guidelines. Fokam J; Takou D; Santoro MM; Akonie HZ; Kouanfack C; Ceccherini-Silberstein F; Colizzi V; Perno CF; Ndjolo A AIDS Res Hum Retroviruses; 2016 Apr; 32(4):329-33. PubMed ID: 26602836 [TBL] [Abstract][Full Text] [Related]
17. Cross-clade simultaneous HIV drug resistance genotyping for reverse transcriptase, protease, and integrase inhibitor mutations by Illumina MiSeq. Dudley DM; Bailey AL; Mehta SH; Hughes AL; Kirk GD; Westergaard RP; O'Connor DH Retrovirology; 2014 Dec; 11():122. PubMed ID: 25533166 [TBL] [Abstract][Full Text] [Related]
18. Drug resistant mutations detected by genotypic drug resistance testing in patients failing therapy in clade C HIV-1 infected individuals from India. Kandathil AJ; Kannangai R; Verghese VP; Pulimood SA; Rupali P; Sridharan G; Grant P; Pillay D; Abraham OC Indian J Med Microbiol; 2009; 27(3):231-6. PubMed ID: 19584504 [TBL] [Abstract][Full Text] [Related]
19. Primary resistance of HIV to antiretrovirals among individuals recently diagnosed at voluntary counselling and testing centres in the metropolitan region of Recife, Pernambuco. Cavalcanti AM; Brito AM; Salustiano DM; Lima KO; Silva SP; Diaz RS; Lacerda HR Mem Inst Oswaldo Cruz; 2012 Jun; 107(4):450-7. PubMed ID: 22666853 [TBL] [Abstract][Full Text] [Related]
20. Incidence of transmitted antiretroviral drug resistance in treatment-naive HIV-1-infected persons in a large South Central United States clinic. Kleyn TJ; Liedtke MD; Harrison DL; Lockhart SM; Salvaggio MR; Ripley TL; Rathbun RC Ann Pharmacother; 2014 Apr; 48(4):470-5. PubMed ID: 24473489 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]